HTL Biotechnology launches HTL8
A new production unit dedicated to pharmaceutical-grade Polynucleotides (DNA) at our Javené site.
Articles
April 4, 2023
SFB & TERMIS Americas
April 2023
We were thrilled to have been a Gold sponsor at the SFB conference this year.
Our business manager, Patrick McDaniel, our Chief Scientific Officer, Anthony Bresin, our Innovation Project Manager, Mélanie Leroux, and our partner Echelon Biosciences were all in attendance, seeking opportunities to connect with other professionals in the field of Tissue Engineering & Regenerative Medicine.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Press releases November 13, 2026HTL Biotechnology launches HTL8
A new production unit dedicated to pharmaceutical-grade Polynucleotides (DNA) at our Javené site.
-
Articles October 30, 20262026 Regenerative Science Summit
HTL Biotechnology hosted a scientific summit in Chengdu, China, dedicated to PDRN/PN, bringing together more than 130 experts and professionals to discuss the latest scientific advances, regulatory developments and emerging applications.
-
Articles September 8, 2026HTL Biotechnology releases its 2025 CSR Report
Driven by the collective commitment of our teams, this report confirms the maturity of an internationally recognized approach, which was recognized this year with the EcoVadis Platinum medal, placing HTL Biotechnology among the top 1% of the world’s most committed companies.